1. Home
  2. SYBX vs DLPN Comparison

SYBX vs DLPN Comparison

Compare SYBX & DLPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYBX
  • DLPN
  • Stock Information
  • Founded
  • SYBX N/A
  • DLPN 1996
  • Country
  • SYBX United States
  • DLPN United States
  • Employees
  • SYBX N/A
  • DLPN N/A
  • Industry
  • SYBX Biotechnology: Pharmaceutical Preparations
  • DLPN Other Consumer Services
  • Sector
  • SYBX Health Care
  • DLPN Consumer Discretionary
  • Exchange
  • SYBX Nasdaq
  • DLPN Nasdaq
  • Market Cap
  • SYBX 13.9M
  • DLPN 12.6M
  • IPO Year
  • SYBX N/A
  • DLPN N/A
  • Fundamental
  • Price
  • SYBX $1.48
  • DLPN $1.12
  • Analyst Decision
  • SYBX
  • DLPN Strong Buy
  • Analyst Count
  • SYBX 0
  • DLPN 1
  • Target Price
  • SYBX N/A
  • DLPN $5.00
  • AVG Volume (30 Days)
  • SYBX 96.1K
  • DLPN 50.2K
  • Earning Date
  • SYBX 08-15-2025
  • DLPN 08-13-2025
  • Dividend Yield
  • SYBX N/A
  • DLPN N/A
  • EPS Growth
  • SYBX N/A
  • DLPN N/A
  • EPS
  • SYBX 0.21
  • DLPN N/A
  • Revenue
  • SYBX N/A
  • DLPN $48,618,803.00
  • Revenue This Year
  • SYBX N/A
  • DLPN $6.57
  • Revenue Next Year
  • SYBX N/A
  • DLPN $18.10
  • P/E Ratio
  • SYBX $7.06
  • DLPN N/A
  • Revenue Growth
  • SYBX N/A
  • DLPN 0.31
  • 52 Week Low
  • SYBX $0.90
  • DLPN $0.75
  • 52 Week High
  • SYBX $1.96
  • DLPN $1.74
  • Technical
  • Relative Strength Index (RSI)
  • SYBX 52.72
  • DLPN 41.03
  • Support Level
  • SYBX $1.53
  • DLPN $1.18
  • Resistance Level
  • SYBX $1.96
  • DLPN $1.42
  • Average True Range (ATR)
  • SYBX 0.19
  • DLPN 0.11
  • MACD
  • SYBX -0.01
  • DLPN -0.02
  • Stochastic Oscillator
  • SYBX 36.84
  • DLPN 21.43

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

Share on Social Networks: